The three Sopharma AD factories - the one in Kazanlak, the Tablet production and Ampoule production in Sofia - have Nivalin in common, one of the strongest Sopharma products. Nivalin is sold in more than 10 countries outside Bulgaria, making it one of the most famous Sopharma products. It increases the intensity of the reflex centers of the spinal cord, medulla oblongata and cerebral cortex, thus influences all links of the reflex arc.
Sopharma AD (3JR: “BSE-Sofia” AD, SPH: Warsaw Stock Exchange) notifies that on 21 June 2018 the Company bought 4 250 own shares representing 0.0032% of the share capital of the Company, at a total value of 18 006.88 BGN on the Bulgarian Stock Exchange, the average price per share was 4.24 BGN.
The trading of treasury shares is pursuant to decision by the Extraordinary General Meeting of Shareholders from 23 February 2018.
The total number of treasury shares after these transactions is 9 074 656, representing 6.73% of the share capital of the Company.
Sopharma AD (3JR: “BSE-Sofia” AD, SPH: Warsaw Stock Exchange) notifies that on 20 June 2018 the Company bought 2 200 own shares representing 0.00163% of the share capital of the Company, at a total value of 9 340.00 BGN on the Bulgarian Stock Exchange, the average price per share was 4.25 BGN.
The trading of treasury shares is pursuant to decision by the Extraordinary General Meeting of Shareholders from 23 February 2018.
The total number of treasury shares after these transactions is 9 070 406, representing 6.73% of the share capital of the Company
Sopharma AD (3JR: “BSE-Sofia” AD, SPH: Warsaw Stock Exchange) notifies that on 19 June 2018 the Company bought 106 own shares representing 0.0000786% of the share capital of the Company, at a total value of 450.50 BGN on the Bulgarian Stock Exchange, the average price per share was 4.25 BGN.
The trading of treasury shares is pursuant to decision by the Extraordinary General Meeting of Shareholders from 23 February 2018.
The total number of treasury shares after these transactions is 9 068 206, representing 6.73% of the share capital of the Company.
